Skip to content
10-K

Annual Report

Galera Therapeutics, Inc. GRTX

0000950170-25-047798

← back to feed
Filed
Mar 31, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 28, 2025 75.46M sh
Stock Issued FY 2024 · Dec 31, 2024 21.07M sh
Stock Issued FY 2024 · Feb 17, 2023 14.32M sh
Capex FY 2024 · Dec 31, 2024 $0
Capex FY 2024 · Dec 31, 2023 $59K
Shares Diluted FY 2024 · Dec 31, 2023 44.55M sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$44.85M
Cash And Equivalents FY 2024 · Dec 31, 2023 $18.26M
Current Liabilities FY 2024 · Dec 31, 2023 $4.96M
Total Liabilities FY 2024 · Dec 31, 2023 $157.33M
Current Assets FY 2024 · Dec 31, 2023 $21.63M
Total Assets FY 2024 · Dec 31, 2023 $26.14M
Eps Diluted FY 2024 · Dec 31, 2023 −$1.33
Eps Basic FY 2024 · Dec 31, 2023 −$1.33
Sga Expense FY 2024 · Dec 31, 2023 $22.84M
Rd Expense FY 2024 · Dec 31, 2023 $24.12M
Net Income FY 2024 · Dec 31, 2023 −$59.08M
Operating Income FY 2024 · Dec 31, 2023 −$49.26M
Stockholders Equity FY 2024 · Dec 31, 2022 −$109.18M